Lippo Cikarang Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Lippo Cikarang Tbk trades at Rp610 (market cap 3.16T, 347.4K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Lippo Cikarang Tbk is far larger — about 6.7× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 347.4K). Which is the better fit depends on your goals.
| LPCK | PRDL | |
|---|---|---|
Market Cap | 3.16T | 470.58B |
Volume | 347.4K | 28.43M |
Lot | 3.47K | 284.34K |
Turnover | 211.93M | 7.8B |
Average Price | 610.04 | 274.19 |
Value | 211.93M | 7.8B |
Indicative Equilibrium Price | 610 | 270 |
Indicative Equilibrium Volume | 102 | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Lippo Cikarang Tbk was established in the Republic of Indonesia the framework of the Domestic Capital Investment Law on July 20, 1987 based on Notarial Deed No.43 of Hendra Karyadi, S.H., as amended by Notarial Deed No. 63 of the same notary dated April 22, 1998.
Read more on LPCK →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →